SCHEMBL21492993

SCHEMBL21492993

O=S(=O)(O)CCCCOS(=O)(=O)CCCCO

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.37
CA2 P00918 8/20 0.33
CA1 P00915 7/20 0.33
CA9 Q16790 7/20 0.33
LMNA P02545 4/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
ALOX15 P16050 2/20 0.33
POLB P06746 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
BLM P54132 2/20 0.33
USP2 O75604 1/20 0.33
MMP9 P14780 1/20 0.33
TSHR P16473 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
BRCA1 P38398 1/20 0.33
HTT P42858 1/20 0.33
GMNN O75496 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9859212 0.90 APP (0.38) APPCA2CA1CA9LMNA
SCHEMBL28560570 0.90 CA1 (0.34) APPCA2CA1CA9LMNA
SCHEMBL29170917 0.87 APP (0.42) APPCA2CA1CA9LMNA
SCHEMBL11979583 0.83 APP (0.42) APPCA2CA1CA9LMNA
SCHEMBL27498636 0.82 CA1 (0.48) CA2CA1CA9LMNAALDH1A1
SCHEMBL29104749 0.81 APP (0.44) APPLMNABLMPTGS1PDE4A
SCHEMBL27583722 0.80 APP (0.37) APPCA2CA1CA9LMNA
SCHEMBL51852 0.80
SCHEMBL28479330 0.79 CA2 (0.33) CA2CA1CA9LMNAALDH1A1
SCHEMBL27583866 0.78 CA2 (0.35) APPCA2CA1CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190321334-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA PRESBYOPIA THERAPIES, INC. 2019-10-24 US disclosed
WO-2019204401-A1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA PRESBYOPIA THERAPIES LLC (US) 2019-10-24 WO disclosed